— Fundamental Stock Analysis and Report Card
Located in Spring Branch, TX, US. Callan JMB Inc., operating primarily through its subsidiary Coldchain Technology Services, LLC, specializes in providing temperature-controlled logistics solutions specifically for the life sciences sector. The company's services include comprehensive frozen shipping capabilities essential for a wide range of sensitive biological and medical materials. These critical shipments encompass items such as personalized medicines, cell-based therapies, stem cells, cell lines, vaccines, diagnostic samples, reproductive materials (including semen, eggs, and embryos), cord blood, organs, biopharmaceutical products, infectious substances, and other vital commodities. Additionally, Callan JMB Inc. offers packaging services for other perishable (non-pharmaceutical) client goods, alongside technical support. The company was founded in 2006 and is based in Spring Branch, Texas.
Revenue, earnings and profitability.
Strong revenue growth and earnings can attract investors, driving the stock price up. Profitability indicates the company's efficiency and sustainability, which impacts investor confidence. Poor performance in these areas can lead to a decrease in stock price.
Revenue History
Earnings History
Margins
Income & Cash Flow analysis.
An income statement shows what a company earned and spent over a period — revenue at the top, costs and expenses in between, and net income at the bottom. A cash flow statement tracks the actual cash moving in and out, across operations, investing, and financing. Read together, they show whether reported earnings are backed by real cash.
Q1 2026 Total ($) | Q1 2026 Margin (%) | |
|---|---|---|
| Revenue | 1.1m -343.2k -23.7% | |
| Gross Income | 427.2k -188.7k -30.6% | 39% -3.9pp -9.1% |
| EBITDA | -3.2m -2.0m -165.2% | -287% -204.6pp -247.4% |
| Operating Income | -1.7m -462.8k -37.4% | -154% -68.4pp -80.0% |
| Net Income | -3.2m -2.0m -159.2% | -291% -205.1pp -239.6% |
| Earnings Per Share | -0.59 -0.3 -84.4% | |
| Operating Cash Flow | -1.7m -118.2k -7.6% | -152% -44.1pp -40.9% |
| Free Cash Flow | -1.7m -138.5k -8.8% | -155% -46.3pp -42.5% |
| Research & Development | n/a n/a n/a | n/a n/a n/a |